Antibacterial Activities of Iron Chelators against Common Nosocomial Pathogens
- 1 October 2012
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (10), 5419-5421
- https://doi.org/10.1128/aac.01197-12
Abstract
The activities of iron chelators (deferoxamine, deferiprone, Apo6619, and VK28) were evaluated against type strains of Acinetobacter baumannii , Pseudomonas aeruginosa , Staphylococcus aureus , Klebsiella pneumoniae , and Escherichia coli . Deferiprone, Apo6619, and VK28 each inhibited growth in standard and RPMI tissue culture medium, while deferoxamine had no effect. Additionally, time-kill assays revealed that VK28 had a bacteriostatic effect against S. aureus . Therefore, these newly developed iron chelators might provide a nontraditional approach for treatment of bacterial infections.This publication has 25 references indexed in Scilit:
- A Record Of 1320 Suspect, Deferasirox-Related, Patient Deaths Reported In 2009: Insufficient Toxicity Testing, Low Efficacy And Lack Of Transparency May Endanger The Lives Of Iron Loaded PatientsHemoglobin, 2011
- Activity of Deferasirox in Mucorales : Influences of Species and Exogenous IronAntimicrobial Agents and Chemotherapy, 2011
- In vitro inhibition of bacterial growth by iron chelatorsFEMS Microbiology Letters, 2010
- Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9Molecular Pharmacology, 2010
- In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificusEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Effects of Chelators (Deferoxamine, Deferiprone and Deferasirox) on the Growth ofKlebsiella PneumoniaeandAeromonas HydrophilaIsolated from Transfusion-Dependent Thalassemia PatientsHemoglobin, 2009
- Antifungal Activities of Natural and Synthetic Iron Chelators Alone and in Combination with Azole and Polyene Antibiotics against Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2009
- Effect of Iron-Chelator Deferiprone on the In Vitro Growth of StaphylococciJournal of Korean Medical Science, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Failure of Deferasirox, an Iron Chelator Agent, Combined with Antifungals in a Case of Severe ZygomycosisAntimicrobial Agents and Chemotherapy, 2008